$FLGT News

Fulgent to Announce Third Quarter 2026 Financial Results on Thursday, November 5, 2026

PRPO vs. FLGT: Which Cancer Diagnostics Stock Has More Upside Now?

Fulgent Genetics (FLGT) Q2 2026 Earnings Call Transcript

Fulgent Genetics, Inc. 2026 Q2 - Results - Earnings Call Presentation

Fulgent Genetics (FLGT) Stock Gets Fair Value Boost After Analysts Raised Targets

Piper Sandler Maintains Neutral on Fulgent Genetics, Raises Price Target to $19

Fulgent Genetics, Inc. Q2 2026 Earnings Call Summary

Fulgent Genetics, Inc. (FLGT) Q2 2026 Earnings Call Transcript

Fulgent Genetics Inc (FLGT) (Q2 2026) Earnings Call Highlights: Strategic Progress Amid Revenue ...

Fulgent Genetics (NASDAQ:FLGT) Plunges 10.6% After Q2 Miss and Guidance Cut

Fulgent Genetics Q2 Earnings Call Highlights

Fulgent Genetics, Inc. (FLGT) Reports Q2 Loss, Misses Revenue Estimates

Fulgent Reports Second Quarter 2026 Financial Results

Fulgent Genetics Lowers FY2026 Adj EPS Guidance from $(1.59) to $(2.35)-$(2.22) vs $(1.55) Est; Lowers FY2026 Sales Guidance from $350.000M to $330.000M-$340.000M vs $351.900M Est

Fulgent Genetics Q2 Adj. EPS $(0.58) Misses $(0.46) Estimate, Sales $85.389M Miss $94.000M Estimate

Fulgent Genetics: Strong Moves By Management Keep Me Bullish

Fulgent to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026

Fulgent Genetics (FLGT) Stock Faces Mixed Analyst Target Changes After Margin Questions

How The Fulgent Genetics (FLGT) Investment Story Is Evolving With Recent Developments

Fulgent Presents Updated FID-007 Data at ASCO 2026